 | • レポートコード：D005-03681 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、CD抗原がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。CD抗原がん治療の種類別市場規模（モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AryoGen Biopharma、Hetero Drugs、Celltrion、Biocad、GLYCART Biotechnology、Biogen Idec、MedImmune、Genmab、Genentech、mAbxience、Merck、Sandoz、UCB ・地域別グローバル市場分析 2015年-2020年 ・CD抗原がん治療の北米市場（アメリカ、カナダ、メキシコ） ・CD抗原がん治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CD抗原がん治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CD抗原がん治療の南米市場（ブラジル、アルゼンチン） ・CD抗原がん治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global CD Antigen Cancer Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The CD Antigen Cancer Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
CD Antigen Cancer Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, CD Antigen Cancer Therapy market has been segmented into
Monoclonal Antibodies
Antibody-Drug-Conjugates
Tri-Functional and Bi-Specific T-Cell Engager Antibodies
Other
By Application, CD Antigen Cancer Therapy has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CD Antigen Cancer Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level CD Antigen Cancer Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CD Antigen Cancer Therapy market.
The report offers in-depth assessment of the growth and other aspects of the CD Antigen Cancer Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and CD Antigen Cancer Therapy Market Share Analysis
CD Antigen Cancer Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CD Antigen Cancer Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CD Antigen Cancer Therapy sales, revenue and market share for each player covered in this report.
The major players covered in CD Antigen Cancer Therapy are:
AryoGen Biopharma
Hetero Drugs
Celltrion
Biocad
GLYCART Biotechnology
Biogen Idec
MedImmune
Genmab
Genentech
mAbxience
Merck
Sandoz
UCB
Among other players domestic and global, CD Antigen Cancer Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CD Antigen Cancer Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of CD Antigen Cancer Therapy, with price, sales, revenue and global market share of CD Antigen Cancer Therapy in 2018 and 2019.
Chapter 3, the CD Antigen Cancer Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CD Antigen Cancer Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, CD Antigen Cancer Therapy market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe CD Antigen Cancer Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 CD Antigen Cancer Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global CD Antigen Cancer Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug-Conjugates
1.2.4 Tri-Functional and Bi-Specific T-Cell Engager Antibodies
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global CD Antigen Cancer Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global CD Antigen Cancer Therapy Market
1.4.1 Global CD Antigen Cancer Therapy Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AryoGen Biopharma
2.1.1 AryoGen Biopharma Details
2.1.2 AryoGen Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AryoGen Biopharma SWOT Analysis
2.1.4 AryoGen Biopharma Product and Services
2.1.5 AryoGen Biopharma CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hetero Drugs
2.2.1 Hetero Drugs Details
2.2.2 Hetero Drugs Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hetero Drugs SWOT Analysis
2.2.4 Hetero Drugs Product and Services
2.2.5 Hetero Drugs CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celltrion SWOT Analysis
2.3.4 Celltrion Product and Services
2.3.5 Celltrion CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biocad
2.4.1 Biocad Details
2.4.2 Biocad Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biocad SWOT Analysis
2.4.4 Biocad Product and Services
2.4.5 Biocad CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GLYCART Biotechnology
2.5.1 GLYCART Biotechnology Details
2.5.2 GLYCART Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GLYCART Biotechnology SWOT Analysis
2.5.4 GLYCART Biotechnology Product and Services
2.5.5 GLYCART Biotechnology CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biogen Idec
2.6.1 Biogen Idec Details
2.6.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biogen Idec SWOT Analysis
2.6.4 Biogen Idec Product and Services
2.6.5 Biogen Idec CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 MedImmune
2.7.1 MedImmune Details
2.7.2 MedImmune Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 MedImmune SWOT Analysis
2.7.4 MedImmune Product and Services
2.7.5 MedImmune CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genmab
2.8.1 Genmab Details
2.8.2 Genmab Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genmab SWOT Analysis
2.8.4 Genmab Product and Services
2.8.5 Genmab CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genentech SWOT Analysis
2.9.4 Genentech Product and Services
2.9.5 Genentech CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 mAbxience
2.10.1 mAbxience Details
2.10.2 mAbxience Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 mAbxience SWOT Analysis
2.10.4 mAbxience Product and Services
2.10.5 mAbxience CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck SWOT Analysis
2.11.4 Merck Product and Services
2.11.5 Merck CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sandoz
2.12.1 Sandoz Details
2.12.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sandoz SWOT Analysis
2.12.4 Sandoz Product and Services
2.12.5 Sandoz CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 UCB
2.13.1 UCB Details
2.13.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 UCB SWOT Analysis
2.13.4 UCB Product and Services
2.13.5 UCB CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global CD Antigen Cancer Therapy Sales and Market Share by Manufacturer (2018-2019)
3.2 Global CD Antigen Cancer Therapy Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 CD Antigen Cancer Therapy Manufacturer Market Share in 2019
3.3.2 Top 6 CD Antigen Cancer Therapy Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global CD Antigen Cancer Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global CD Antigen Cancer Therapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global CD Antigen Cancer Therapy Revenue and Market Share by Regions (2015-2020)
4.2 North America CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
4.3 Europe CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
4.5 South America CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America CD Antigen Cancer Therapy Sales, Revenue and Market Share by Country
5.1.1 North America CD Antigen Cancer Therapy Sales and Market Share by Country (2015-2020)
5.1.2 North America CD Antigen Cancer Therapy Revenue and Market Share by Country (2015-2020)
5.2 United States CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
5.3 Canada CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
5.4 Mexico CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe CD Antigen Cancer Therapy Sales, Revenue and Market Share by Country
6.1.1 Europe CD Antigen Cancer Therapy Sales and Market Share by Country (2015-2020)
6.1.2 Europe CD Antigen Cancer Therapy Revenue and Market Share by Country (2015-2020)
6.2 Germany CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
6.3 UK CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
6.4 France CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
6.5 Russia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
6.6 Italy CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific CD Antigen Cancer Therapy Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific CD Antigen Cancer Therapy Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific CD Antigen Cancer Therapy Revenue and Market Share by Regions (2015-2020)
7.2 China CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
7.3 Japan CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
7.4 Korea CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
7.5 India CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
7.6 Southeast Asia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
7.7 Australia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America CD Antigen Cancer Therapy Sales, Revenue and Market Share by Country
8.1.1 South America CD Antigen Cancer Therapy Sales and Market Share by Country (2015-2020)
8.1.2 South America CD Antigen Cancer Therapy Revenue and Market Share by Country (2015-2020)
8.2 Brazil CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
8.3 Argentina CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa CD Antigen Cancer Therapy Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa CD Antigen Cancer Therapy Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa CD Antigen Cancer Therapy Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
9.3 Turkey CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
9.4 Egypt CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
9.5 South Africa CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global CD Antigen Cancer Therapy Sales and Market Share by Type (2015-2020)
10.2 Global CD Antigen Cancer Therapy Revenue and Market Share by Type (2015-2020)
10.3 Global CD Antigen Cancer Therapy Price by Type (2015-2020)
11 Global CD Antigen Cancer Therapy Market Segment by Application
11.1 Global CD Antigen Cancer Therapy Sales Market Share by Application (2015-2020)
11.2 Global CD Antigen Cancer Therapy Revenue Market Share by Application (2015-2020)
11.3 Global CD Antigen Cancer Therapy Price by Application (2015-2020)
12 Market Forecast
12.1 Global CD Antigen Cancer Therapy Sales, Revenue and Growth Rate (2021-2025)
12.2 CD Antigen Cancer Therapy Market Forecast by Regions (2021-2025)
12.2.1 North America CD Antigen Cancer Therapy Market Forecast (2021-2025)
12.2.2 Europe CD Antigen Cancer Therapy Market Forecast (2021-2025)
12.2.3 Asia-Pacific CD Antigen Cancer Therapy Market Forecast (2021-2025)
12.2.4 South America CD Antigen Cancer Therapy Market Forecast (2021-2025)
12.2.5 Middle East & Africa CD Antigen Cancer Therapy Market Forecast (2021-2025)
12.3 CD Antigen Cancer Therapy Market Forecast by Type (2021-2025)
12.3.1 Global CD Antigen Cancer Therapy Sales Forecast by Type (2021-2025)
12.3.2 Global CD Antigen Cancer Therapy Market Share Forecast by Type (2021-2025)
12.4 CD Antigen Cancer Therapy Market Forecast by Application (2021-2025)
12.4.1 Global CD Antigen Cancer Therapy Sales Forecast by Application (2021-2025)
12.4.2 Global CD Antigen Cancer Therapy Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global CD Antigen Cancer Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CD Antigen Cancer Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CD Antigen Cancer Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AryoGen Biopharma Basic Information, Manufacturing Base and Competitors
Table 8. AryoGen Biopharma CD Antigen Cancer Therapy Major Business
Table 9. AryoGen Biopharma CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 10. AryoGen Biopharma SWOT Analysis
Table 11. AryoGen Biopharma CD Antigen Cancer Therapy Product and Services
Table 12. AryoGen Biopharma CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 14. Hetero Drugs CD Antigen Cancer Therapy Major Business
Table 15. Hetero Drugs CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 16. Hetero Drugs SWOT Analysis
Table 17. Hetero Drugs CD Antigen Cancer Therapy Product and Services
Table 18. Hetero Drugs CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion CD Antigen Cancer Therapy Major Business
Table 21. Celltrion CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 22. Celltrion SWOT Analysis
Table 23. Celltrion CD Antigen Cancer Therapy Product and Services
Table 24. Celltrion CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Biocad Basic Information, Manufacturing Base and Competitors
Table 26. Biocad CD Antigen Cancer Therapy Major Business
Table 27. Biocad CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 28. Biocad SWOT Analysis
Table 29. Biocad CD Antigen Cancer Therapy Product and Services
Table 30. Biocad CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GLYCART Biotechnology Basic Information, Manufacturing Base and Competitors
Table 32. GLYCART Biotechnology CD Antigen Cancer Therapy Major Business
Table 33. GLYCART Biotechnology CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 34. GLYCART Biotechnology SWOT Analysis
Table 35. GLYCART Biotechnology CD Antigen Cancer Therapy Product and Services
Table 36. GLYCART Biotechnology CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 38. Biogen Idec CD Antigen Cancer Therapy Major Business
Table 39. Biogen Idec CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 40. Biogen Idec SWOT Analysis
Table 41. Biogen Idec CD Antigen Cancer Therapy Product and Services
Table 42. Biogen Idec CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. MedImmune Basic Information, Manufacturing Base and Competitors
Table 44. MedImmune CD Antigen Cancer Therapy Major Business
Table 45. MedImmune CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 46. MedImmune SWOT Analysis
Table 47. MedImmune CD Antigen Cancer Therapy Product and Services
Table 48. MedImmune CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genmab Basic Information, Manufacturing Base and Competitors
Table 50. Genmab CD Antigen Cancer Therapy Major Business
Table 51. Genmab CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 52. Genmab SWOT Analysis
Table 53. Genmab CD Antigen Cancer Therapy Product and Services
Table 54. Genmab CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Genentech Basic Information, Manufacturing Base and Competitors
Table 56. Genentech CD Antigen Cancer Therapy Major Business
Table 57. Genentech CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 58. Genentech SWOT Analysis
Table 59. Genentech CD Antigen Cancer Therapy Product and Services
Table 60. Genentech CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. mAbxience Basic Information, Manufacturing Base and Competitors
Table 62. mAbxience CD Antigen Cancer Therapy Major Business
Table 63. mAbxience CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 64. mAbxience SWOT Analysis
Table 65. mAbxience CD Antigen Cancer Therapy Product and Services
Table 66. mAbxience CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck CD Antigen Cancer Therapy Major Business
Table 69. Merck CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 70. Merck SWOT Analysis
Table 71. Merck CD Antigen Cancer Therapy Product and Services
Table 72. Merck CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sandoz Basic Information, Manufacturing Base and Competitors
Table 74. Sandoz CD Antigen Cancer Therapy Major Business
Table 75. Sandoz CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 76. Sandoz SWOT Analysis
Table 77. Sandoz CD Antigen Cancer Therapy Product and Services
Table 78. Sandoz CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. UCB Basic Information, Manufacturing Base and Competitors
Table 80. UCB CD Antigen Cancer Therapy Major Business
Table 81. UCB CD Antigen Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 82. UCB SWOT Analysis
Table 83. UCB CD Antigen Cancer Therapy Product and Services
Table 84. UCB CD Antigen Cancer Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global CD Antigen Cancer Therapy Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global CD Antigen Cancer Therapy Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global CD Antigen Cancer Therapy Sales by Regions (2015-2020) (K Units)
Table 88. Global CD Antigen Cancer Therapy Sales Market Share by Regions (2015-2020)
Table 89. Global CD Antigen Cancer Therapy Revenue by Regions (2015-2020) (USD Million)
Table 90. North America CD Antigen Cancer Therapy Sales by Countries (2015-2020) (K Units)
Table 91. North America CD Antigen Cancer Therapy Sales Market Share by Countries (2015-2020)
Table 92. North America CD Antigen Cancer Therapy Revenue by Countries (2015-2020) (USD Million)
Table 93. North America CD Antigen Cancer Therapy Revenue Market Share by Countries (2015-2020)
Table 94. Europe CD Antigen Cancer Therapy Sales by Countries (2015-2020) (K Units)
Table 95. Europe CD Antigen Cancer Therapy Sales Market Share by Countries (2015-2020)
Table 96. Europe CD Antigen Cancer Therapy Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific CD Antigen Cancer Therapy Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific CD Antigen Cancer Therapy Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific CD Antigen Cancer Therapy Revenue by Regions (2015-2020) (USD Million)
Table 100. South America CD Antigen Cancer Therapy Sales by Countries (2015-2020) (K Units)
Table 101. South America CD Antigen Cancer Therapy Sales Market Share by Countries (2015-2020)
Table 102. South America CD Antigen Cancer Therapy Revenue by Countries (2015-2020) (USD Million)
Table 103. South America CD Antigen Cancer Therapy Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa CD Antigen Cancer Therapy Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa CD Antigen Cancer Therapy Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa CD Antigen Cancer Therapy Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa CD Antigen Cancer Therapy Revenue Market Share by Countries (2015-2020)
Table 108. Global CD Antigen Cancer Therapy Sales by Type (2015-2020) (K Units)
Table 109. Global CD Antigen Cancer Therapy Sales Share by Type (2015-2020)
Table 110. Global CD Antigen Cancer Therapy Revenue by Type (2015-2020) (USD Million)
Table 111. Global CD Antigen Cancer Therapy Revenue Share by Type (2015-2020)
Table 112. Global CD Antigen Cancer Therapy Sales by Application (2015-2020) (K Units)
Table 113. Global CD Antigen Cancer Therapy Sales Share by Application (2015-2020)
Table 114. Global CD Antigen Cancer Therapy Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global CD Antigen Cancer Therapy Market Share Forecast by Regions (2021-2025)
Table 116. Global CD Antigen Cancer Therapy Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global CD Antigen Cancer Therapy Market Share Forecast by Type (2021-2025)
Table 118. Global CD Antigen Cancer Therapy Sales Forecast by Application (2021-2025)
Table 119. Global CD Antigen Cancer Therapy Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. CD Antigen Cancer Therapy Picture
Figure 2. Global Sales Market Share of CD Antigen Cancer Therapy by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Antibody-Drug-Conjugates Picture
Figure 5. Tri-Functional and Bi-Specific T-Cell Engager Antibodies Picture
Figure 6. Other Picture
Figure 7. CD Antigen Cancer Therapy Sales Market Share by Application in 2018
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Other Picture
Figure 11. Global CD Antigen Cancer Therapy Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey CD Antigen Cancer Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global CD Antigen Cancer Therapy Sales Market Share by Manufacturer in 2019
Figure 32. Global CD Antigen Cancer Therapy Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 CD Antigen Cancer Therapy Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 CD Antigen Cancer Therapy Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global CD Antigen Cancer Therapy Revenue Market Share by Regions (2015-2020)
Figure 39. Global CD Antigen Cancer Therapy Revenue Market Share by Regions in 2018
Figure 40. North America CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
Figure 41. Europe CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
Figure 43. South America CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020)
Figure 45. North America CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America CD Antigen Cancer Therapy Sales Market Share by Countries (2015-2020)
Figure 47. North America CD Antigen Cancer Therapy Sales Market Share by Countries in 2018
Figure 48. North America CD Antigen Cancer Therapy Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America CD Antigen Cancer Therapy Revenue Market Share by Countries in 2018
Figure 50. United States CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe CD Antigen Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 55. Europe CD Antigen Cancer Therapy Revenue Market Share by Countries in 2019
Figure 56. Germany CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific CD Antigen Cancer Therapy Sales Market Share by Regions 2019
Figure 63. Asia-Pacific CD Antigen Cancer Therapy Revenue Market Share by Regions 2019
Figure 64. China CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America CD Antigen Cancer Therapy Sales Market Share by Countries in 2019
Figure 71. South America CD Antigen Cancer Therapy Revenue Market Share by Countries in 2019
Figure 72. Brazil CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa CD Antigen Cancer Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa CD Antigen Cancer Therapy Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa CD Antigen Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa CD Antigen Cancer Therapy Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa CD Antigen Cancer Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global CD Antigen Cancer Therapy Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global CD Antigen Cancer Therapy Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales CD Antigen Cancer Therapy Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales CD Antigen Cancer Therapy Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales CD Antigen Cancer Therapy Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales CD Antigen Cancer Therapy Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales CD Antigen Cancer Therapy Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
CEACAM8（抗原遺伝子）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global CEACAM8(Antigen gene) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The CEACAM8(Antigen gene) m…- 併用療法薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combination Therapy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Combination Therapy …
- 抗原ELISAキットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antigen ELISA Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antigen ELISA Kit market re…
- 冷圧療法製品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cold Compression Therapy Product market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cold Compres…
- 樹状細胞がんワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dendritic Cell …